Log In
BCIQ
Print this Print this
 

Hypertension vaccine

  Manage Alerts
Collapse Summary General Information
Company Affiris AG
DescriptionVaccine targeting angiotensin II developed using AFFITOME technology
Molecular Target Angiotensin II type 1 (AT1) receptor (AGTR1) ; Angiotensin II type 2 (AT2) receptor (ATGR2)
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationHypertension
Indication DetailsVaccinate against hypertension
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today